Raymond James & Associates’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-24,584
Closed -$531K 3878
2023
Q3
$531K Sell
24,584
-60,906
-71% -$1.35M ﹤0.01% 2850
2023
Q2
$2.1M Sell
85,490
-523
-0.6% -$13K ﹤0.01% 2029
2023
Q1
$2.33M Buy
+86,013
New +$2.15M ﹤0.01% 1938

Other funds holding HSTM

Raymond James & Associates's HSTM Position: Q4 2023 in Review

Raymond James & Associates sold out of HealthStream (HSTM) in Q4 2023, closing a stake of 24,584 shares — an estimated $531K sold.

Raymond James & Associates first reported a position in HSTM in Q1 2023 and held it in 3 quarters. The position peaked at $2.33M in Q1 2023. 188 funds tracked by Wall St. Rank hold HSTM as of Q4 2023.

  • Raymond James & Associates reported no remaining HealthStream position as of Q4 2023 after selling out during the quarter.
  • Raymond James & Associates sold 24,584 HealthStream shares in Q4 2023, an estimated $531K.
  • Raymond James & Associates first reported a position in HealthStream in Q1 2023 and held it in 3 quarters.
  • Raymond James & Associates's HealthStream position peaked at $2.33M in Q1 2023.
  • 188 funds tracked by Wall St. Rank held HealthStream as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.